Amy E McKee
Director at Biocryst Pharmaceuticals Inc (BCRX) since September 2021
Amy E McKee has filed 14 insider reports with the SEC since September 2021, as director at Biocryst Pharmaceuticals Inc (BCRX). In the last 12 months Amy E McKee sold $100K of stock on the open market. The latest filing, on September 2, 2026, reports grant or award at Biocryst Pharmaceuticals Inc (BCRX).
- Filings
- 14
- Companies
- 1
- Bought on market
- None
- Sold on market
- $155K
Companies where Amy E McKee is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince September 2021 | 47,821 | $155K | $7.32 | Sep 2, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Aug 31, 2026BCRXDirector Mckee Amy E was granted 644 shares, increasing direct ownership by 1% to 47,821 unitsForm 4Grant or award
- Jun 11, 2026BCRXDirector Mckee Amy E was granted 15,294 shares, increasing direct ownership by 48% to 47,177 unitsForm 4Grant or award
- May 29, 2026BCRXDirector Mckee Amy E was granted 631 shares, increasing direct ownership by 2% to 31,883 unitsForm 4Grant or award
- May 18, 2026-$100KBCRXDirector Mckee Amy E sold $100,285 worth of shares (11,180 units at $8.97), decreasing direct ownership by 26% to 31,252 unitsForm 4Open-market sale
- Feb 27, 2026BCRXDirector Mckee Amy E was granted 642 shares, increasing direct ownership by 2% to 42,432 unitsForm 4Grant or award
- Nov 28, 2025BCRXDirector Mckee Amy E was granted 783 shares, increasing direct ownership by 2% to 41,790 unitsForm 4Grant or award
- Aug 29, 2025BCRXDirector Mckee Amy E was granted 676 shares, increasing direct ownership by 2% to 41,007 unitsForm 4Grant or award
- Jun 12, 2025BCRXDirector Mckee Amy E was granted 12,500 shares, increasing direct ownership by 45% to 40,331 unitsForm 4Grant or award
- Jun 24, 2024-$54.4KBCRXDirector Mckee Amy E sold $54,352 worth of shares (8,600 units at $6.32), decreasing direct ownership by 24% to 27,831 unitsForm 4Open-market sale
- Jun 12, 2024BCRXDirector Mckee Amy E was granted 6,820 shares, increasing direct ownership by 23% to 36,431 unitsForm 4Grant or award
- Jun 13, 2023BCRXSEC Form 4 filed by Mckee Amy EForm 4Grant or award
- Jun 7, 2022BCRXSEC Form 4: Mckee Amy E was granted 12,866 sharesForm 4Grant or award
- Sep 20, 2021BCRXSEC Form 4 filed by Mckee Amy EForm 4Grant or award
- Sep 20, 2021BCRXAmy E McKee became an insiderForm 3New insider
Compare Amy E McKee with
- Amy E McKee vs Jon P Stonehouse1 shared
- Amy E McKee vs Jill C. Milne1 shared
- Amy E McKee vs Vincent Milano1 shared
- Amy E McKee vs Steven Frank1 shared
- Amy E McKee vs Steven K Galson1 shared
- Amy E McKee vs Alan G Levin1 shared
Other insiders at the same companies
- Jon P StonehouseBCRX
- Jill C. MilneBCRX
- Vincent MilanoBCRX
- Steven FrankBCRX
- Steven K GalsonBCRX
- Alan G LevinBCRX
- Machelle SandersBCRX
- Theresa HeggieBCRX
- Alane P BarnesBCRX
- Sandeep MenonBCRX
- Ronald DullingerBCRX
- Charles K GayerBCRX
- Babar GhiasBCRX
- Nancy J HutsonBCRX
- Helen M. ThackrayBCRX
- Anthony DoyleBCRX
Questions about Amy E McKee
- What is Amy E McKee's role at Biocryst Pharmaceuticals Inc?
- Amy E McKee reports to the SEC as director at Biocryst Pharmaceuticals Inc (BCRX), according to the latest filing on September 2, 2026.
- How many shares does Amy E McKee own?
- After the latest filing that states it, Amy E McKee directly owned 47,821 shares of Biocryst Pharmaceuticals Inc (BCRX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Amy E McKee bought or sold stock recently?
- The most recent open-market sale was on May 18, 2026: sold 11,180 shares of Biocryst Pharmaceuticals Inc (BCRX) for $100K at an average of $8.97.
- How do I get alerts when Amy E McKee files?
- Follow Amy E McKee on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Amy E McKee filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Amy E McKee (SEC CIK 0001883764). Totals count each trade once, skipping amendments whose original is on file, from Sep 22, 2021 on. View on SEC EDGAR · Get this as JSON